Combination Therapy with Venetoclax for Patients With Chronic Lymphocytic Leukemia

In May 2019, the Food and Drug Administration (FDA) approved venetoclax (Venclexta) in combination with obinutuzumab (Gazyva) for the initial treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). According to Milos Miljković, M.D., who studies Chronic Lymphocytic Leukemia in NCI’s Center for Cancer Research, “This is the 2’nd chemotherapy-free […]

Understanding Rheumatoid Arthritis (RA)

QUICK FACTS : Rheumatoid arthritis is an autoimmune disease triggered by a faulty immune system. Rheumatoid arthritis is the most common type of autoimmune arthritis. Treatments have enhanced broadly and help many of those affected. Rheumatologists can precisely diagnose Rheumatoid Arthritis and recommend treatments. ABOUT RA: Rheumatoid arthritis is a condition that may cause pain, […]

Ustekinumab : Information for Patients and Caregivers

Ustekinumab is also known by the brand name Stelara. It is used to treat moderate to severe active Crohn’s Disease and moderate to severe active Ulcerative Colitis in adults. It can be an option when certain other therapies including steroids, immunosuppressants (such as azathioprine, mercaptopurine, methotrexate) or biologic drugs such as anti-TNF’s infliximab, adalimumab or golimumab […]

Hodgkin’s Lymphoma Treatment

About Adcetris: Adcetris contains an Active Pharmaceutical Ingredient called brentuximab vedotin . It is a prescription medication used to treat adults with certain types of blood cancer. The brentuximab vedotin may be given with chemotherapy (combination therapy) as your first treatment for: Stage-3/4 classical Hodgkin lymphoma (cHL) with medications adriamycin, vinblastine, and dacarbazine (also known as […]

Blincyto Treatment for Acute Lymphoblastic Leukemia

Introduction: Acute lymphoblastic leukemia (ALL) is a sort of blood cancer. ALL can also be addressed by certain other names such as “acute lymphocytic leukemia” and “acute lymphoid leukemia.” ALL is most commonly developed leukemia in children. Advances in the treatment of ALL have resulted increased remission rates. The number of patients who have gone […]